Diabetes Conferences|Dubai |UAE|2017 Diabetes.gavinconferences.com

Conference Theme:


Illuminating Global Consciousness On Diabetes Risks And Endocrinology Disorders


 

About Conference:

Gavin Conferences invites participants from all over the world to attend “International Conference on Diabetes and Endocrinology Disorders. Diabetes 2017 is a three day conference going to be held during May 15-17, 2017 at Dubai, UAE and is open to attendees, academics and non-academic audiences.The three day conference is designed to bring researchers, academicians, doctorates, professors, lecturers and scholars to discuss research and share ideas regarding career interests to make event experience even better. During the event, participants can build networks and share information and ideas with one another.The World Diabetes Foundation estimates that there will be 438 million people with diabetes by the year 2030. It advances our understanding of trends in diabetes prevalence, of the contribution of high blood glucose to premature mortality, and of what action governments are taking to prevent and control diabetes.

Aim:

Our aim is to increase global awareness of Diabetes risks and illuminate consciousness of endocrinology disorders.

Global Market:

The Global Diabetes market featuring insulin products is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment is established with an investment of $13.5 billion. Global Market for Diabetes Therapies & Diagnostics is to be worth $51.2 billion in 2015. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly, the global market value for diabetes therapies and diagnostics is an estimated $38 billion in 2010, but is expected to increase to $51.2 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 6.1 per cent. GBI Research's analysis shows that the overall global endocrinology market was valued at $6.0 billion in 2010. It grew from $4.0 billion in 2004 at a CAGR of 6.9%. The market is expected to witness comparatively moderate

 


Conference Highlights

Type1 & Type 2 Diabetes
Rare Diabetes (MODY)
Gestational Diabetes
Hypoglycemia & Hyperglycemia
Diabetes and related Complications
Lifestyle and Diabetes
Exercise and Diabetes
Weight management and Diabetes
Global diabetes research Trends
Prediabetes Research
Diabetes and Clinical research
Genomics of Diabetes
Genetic link between Obesity and Diabetes
MODY- Maturity onset Diabetes of the Young
Neonatal Diabetes
Monogenic Diabetes
Innovative Medical Technologies in Hospitals
Software Technologies for Diabetic Diagnosis
New Medications for Treatment of Diabetes
Metabolic Syndrome
Cellular Endocrinology
Pediatric Endocrinology
Pediatric Endocrinology
Endocrine Oncology
Behaviorial Endocrinology
Gigantism and Treatment
Hyperthyroidism and Hypothyroidism Treatment
Polycystic Ovarian Syndrome (PCOS) and Treatment
Precocious puberty and Treatment
Catamenial epilepsy
Seizures and Menopausal transition issues
Hypothalamic or pituitary gland lesions
Reproductive hormone disorders in men
Molecular Investigation and Diagnosis
Islet cell transplantation
Comparative biochemistry and physiology
Market Analysis by Diabetes Drug Classes
Leading Industry Products
Market for Insulin
Market for Insulin Analogs
Global Market Overview